Interestingly, we also found HPRT1 expression to be highest in the basal subtype of breast cancer patients, which is the most aggressive cancer and remains a difficult molecular subtype to treat due to its heterogeneity [6]. This evidence concerns the gene HPRT1 and breast carcinoma.